In addition, the pharmacological inhibition of PI3K/AKT may promote colon cancer cell apoptosis by regulating apoptosis-related proteins such as PARP, Bcl2 and Bax, and show effective antitumor effects [12,15]. This evidence concerns the gene BCL2 and malignant colon neoplasm.